Ingevity Corporation (NGVT)
NYSE: NGVT · Real-Time Price · USD
61.72
-0.25 (-0.40%)
Nov 13, 2026, 4:00 PM EST - Market closed
Ingevity Revenue
Ingevity had revenue of $305.10M in the quarter ending September 30, 2026, a decrease of -8.41%. This brings the company's total for the last twelve months to $1.13B, down -6.52% year-over-year. In the year 2025, Ingevity had annual revenue of $1.17B, down -2.71%. That makes Ingevity the 7,110th largest company in the world by revenue and 1,719th in the United States.
Revenue (ttm)
$1.13B
Revenue Growth
-6.52%
P/S Ratio
1.84
Revenue / Employee
$754,867
Employees
1,500
Market Cap
2.08B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Ingevity breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | -32.50M | -2.71% |
| Dec 31, 2024 | 1.20B | -492.00M | -29.08% |
| Dec 31, 2023 | 1.69B | 23.80M | 1.43% |
| Dec 31, 2022 | 1.67B | 276.80M | 19.89% |
| Dec 31, 2021 | 1.39B | 175.40M | 14.42% |
| Dec 31, 2020 | 1.22B | -76.80M | -5.94% |
| Dec 31, 2019 | 1.29B | 159.30M | 14.05% |
| Dec 31, 2018 | 1.13B | 161.20M | 16.58% |
| Dec 31, 2017 | 972.40M | 64.10M | 7.06% |
| Dec 31, 2016 | 908.30M | -50.00M | -5.22% |
| Dec 31, 2015 | 958.30M | -77.20M | -7.46% |
| Dec 31, 2014 | 1.04B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| The Chemours Company | 5.84B |
| Calumet | 5.20B |
| H.B. Fuller Company | 3.55B |
| Stepan Company | 2.53B |
| Minerals Technologies | 2.17B |
| Quaker Chemical | 2.03B |
| Innospec | 1.87B |
| Ashland | 1.86B |
NGVT News
- 9 days ago - Ingevity Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Ingevity Earnings release: Q3 2026 - Filings
- 9 days ago - Ingevity Slides: Q3 2026 - Filings
- 9 days ago - Ingevity Quarterly report: Q3 2026 - Filings
- 10 days ago - Ingevity reports Q3 adjusted EPS $1.63, consensus $1.59 - TheFly
- 10 days ago - Ingevity sees FY26 adjusted EPS $5.25-$5.45, consensus $5.24 - TheFly
- 10 days ago - Ingevity reports third quarter 2026 financial results - Business Wire
- 19 days ago - Ingevity Celebrates 10 Years as a Public Company with NYSE Closing Bell® Ringing - Business Wire